| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.036 | 0.8 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.8 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |